Archive: 2025/12 - Page 3
DOAC Dosing in Obesity: What Works, What Doesn’t, and What You Need to Know
Apixaban and rivaroxaban are safe and effective at standard doses for obese patients. Dabigatran increases bleeding risk. Edoxaban may need monitoring in extreme obesity. No dose escalation is recommended.
How to Manage Interactions When Starting a New Medication
Learn how to safely manage drug interactions when starting a new medication. Avoid dangerous combinations, recognize high-risk pairings, and take practical steps to protect your health with expert-backed strategies.
Seizure Medications and Pregnancy: Risks of Birth Defects and Drug Interactions
Seizure medications can pose serious risks during pregnancy, including birth defects and dangerous drug interactions with birth control. Learn which drugs are safest, how to manage risks, and why planning ahead is critical for women with epilepsy.